Welcome to the upgraded BRAC University Institutional Repository. We are currently organizing collections after a recent system upgrade. Homepage category counters may temporarily show lower numbers while syncing, but over 27,000 repository items remain safe and accessible. Please use the search bar to find theses, scholarly outputs, and institutional documents.

RIPK pathway, as a potential target, for cancer treatment - a review

Simple item page
bracu.degree.levelUndergraduate
bracu.type.groupStudent Works
datacite.rightsOpen Access
dc.contributor.advisorChowdhury, Namara Mariam
dc.contributor.authorJahan, Nusrat
dc.contributor.departmentSchool of Pharmacy
dc.date.accessioned2024-01-02T10:27:12Z
dc.date.available2024-01-02T10:27:12Z
dc.date.copyright2023
dc.date.issued2023-02
dc.descriptionCataloged from PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 45-48).
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.en_US
dc.description.abstractCancer is one of the most feared diseases whose prevalence has been drastically increasing in recent years. Among different types of treatment options, the development of kinase-targeted cancer therapies is currently the most studied target for potential anti-cancer therapies. After G-protein-coupled receptors, protein kinases significantly grab the attraction as a target of developing anti-cancer drugs. Based on current research, this review article outlines receptor-interacting protein kinases specially RIP1 and RIP3 as attractive targets over other kinases in the treatment of numerous types of cancer, especially for their tumorigenesis functions in cancer metastasis.en_US
dc.description.degreeBachelor of Pharmacy
dc.description.statementofresponsibilityNusrat Jahan
dc.format.extent48 pages
dc.identifier.otherID 19146057
dc.identifier.urihttp://hdl.handle.net/10361/22051
dc.language.isoenen_US
dc.publisherBRAC Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectCanceren_US
dc.subjectRIPKen_US
dc.subjectPathwayen_US
dc.subjectInhibitorsen_US
dc.subjectTherapyen_US
dc.subjectAnti-cancer drugsen_US
dc.subject.lcshCancer--Treatment
dc.titleRIPK pathway, as a potential target, for cancer treatment - a reviewen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
19146057_PHR.pdf
Size:
996.35 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Project report & Thesis (Bachelor of Pharmacy)